Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$406M |
| 2 |
Baidu
BIDU
|
+$382M |
| 3 |
AGN
Allergan plc
AGN
|
+$366M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$322M |
| 5 |
NextEra Energy, Inc.
NEE
|
+$312M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.66B |
| 2 |
Meta Platforms (Facebook)
META
|
+$370M |
| 3 |
Pfizer
PFE
|
+$343M |
| 4 |
Gilead Sciences
GILD
|
+$331M |
| 5 |
Amazon
AMZN
|
+$282M |
Sector Composition
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.73% |
| 3 | Consumer Staples | 9.8% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
SI-BONE Inc
SIBN
$677M
| $2.68M | ﹤0.01% |
224,500
+159,200
| +244% | +$1.9M |
|
|
BCLI
1902
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $2.68M | ﹤0.01% |
38,443
+16,181
| +73% | +$1.13M |
|
1903
DXP Enterprises
DXPE
$1.85B
| $2.67M | ﹤0.01% |
218,064
+61,664
| +39% | +$756K |
|
|
LUMO
1904
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $2.66M | ﹤0.01% |
313,091
-13,358
| -4% | -$114K |
|
1905
Avient
AVNT
$3.31B
| $2.65M | ﹤0.01% |
139,858
-695,400
| -83% | -$13.2M |
|
1906
Allstate
ALL
$52.8B
| $2.64M | ﹤0.01% |
28,800
-116,500
| -80% | -$10.7M |
|
1907
Kodiak Sciences
KOD
$489M
| $2.64M | ﹤0.01% |
55,359
-244,000
| -82% | -$11.6M |
|
|
ARC
1908
DELISTED
ARC Document Solutions, Inc.
ARC
| $2.63M | ﹤0.01% |
3,249,338
-302,300
| -9% | -$245K |
|
1909
Belden
BDC
$5.21B
| $2.63M | ﹤0.01% |
72,893
-220,300
| -75% | -$7.95M |
|
1910
Chemung Financial Corp
CHMG
$252M
| $2.63M | ﹤0.01% |
79,688
-5,700
| -7% | -$188K |
|
|
MSGN
1911
DELISTED
MSG Networks Inc.
MSGN
| $2.63M | ﹤0.01% |
257,600
-706,600
| -73% | -$7.21M |
|
1912
Nicolet Bankshares
NIC
$2B
| $2.62M | ﹤0.01% |
47,995
-12,400
| -21% | -$677K |
|
1913
Spero Therapeutics
SPRO
$107M
| $2.62M | ﹤0.01% |
324,303
-13,900
| -4% | -$112K |
|
1914
Acadia Realty Trust
AKR
$2.64B
| $2.61M | ﹤0.01% |
210,417
+63,016
| +43% | +$781K |
|
|
EMKR
1915
DELISTED
Emcore Corp
EMKR
| $2.6M | ﹤0.01% |
116,227
-6,230
| -5% | -$140K |
|
1916
Customers Bancorp
CUBI
$2.32B
| $2.6M | ﹤0.01% |
237,466
-48,943
| -17% | -$535K |
|
1917
Ferrari
RACE
$85.1B
| $2.59M | ﹤0.01% |
17,000
-261,568
| -94% | -$39.9M |
|
|
TCDA
1918
DELISTED
Tricida, Inc. Common Stock
TCDA
| $2.59M | ﹤0.01% |
117,800
+87,600
| +290% | +$1.93M |
|
1919
Standard Motor Products
SMP
$889M
| $2.59M | ﹤0.01% |
62,300
+22,100
| +55% | +$919K |
|
|
OIIM
1920
DELISTED
02Micro International Limited
OIIM
| $2.59M | ﹤0.01% |
2,012,174
-74,486
| -4% | -$95.7K |
|
1921
Westamerica Bancorp
WABC
$1.24B
| $2.58M | ﹤0.01% |
43,900
+1,269
| +3% | +$74.6K |
|
1922
Option Care Health
OPCH
$4.62B
| $2.57M | ﹤0.01% |
271,756
-137,583
| -34% | -$1.3M |
|
1923
Townsquare Media
TSQ
$115M
| $2.57M | ﹤0.01% |
558,437
+82,000
| +17% | +$378K |
|
|
BDSI
1924
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.57M | ﹤0.01% |
678,400
-432,951
| -39% | -$1.64M |
|
1925
Acadia Pharmaceuticals
ACAD
$3.98B
| $2.57M | ﹤0.01% |
60,800
-670,200
| -92% | -$28.3M |
|